Dose of prophylactic platelet transfusions and prevention of hemorrhage

New England Journal of Medicine

Volumn 362, Issue 7, 2010, Pages 600-613

  Slichter, Sherrill J ^a   Kaufman, Richard M ^b   Assmann, Susan F ^e   McCullough, Jeffrey ^f   Triulzi, Darrell J ^g   Strauss, Ronald G ^h   Gernsheimer, Terry B ^a   Ness, Paul M ⁱ   Brecher, Mark E ^k   Josephson, Cassandra D ^l   Konkle, Barbara A ^m   Woodson, Robert D ^o,p   Ortel, Thomas L ^q   Hillyer, Christopher D ^l   Skerrett, Donna L ^r   McCrae, Keith R ^s   Sloan, Steven R ^c   Uhl, Lynne ^d   George, James N ^t   Aquino, Victor M ^u   Manno, Catherine S ⁿ   McFarland, Janice G ^o,p   Hess, John R ^j   Leissinger, Cindy ^v   Granger, Suzanne ^e   more..

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^e NEW ENGLAND RESEARCH INSTITUTES   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^g UNIVERSITY OF PITTSBURGH   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ JOHNS HOPKINS UNIVERSITY   (United States)

^j UNIVERSITY OF MARYLAND   (United States)

^k UNIVERSITY OF NORTH CAROLINA   (United States)

^l EMORY UNIVERSITY   (United States)

^m UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^o BLOOD RESEARCH INSTITUTE   (United States)

^p UNIVERSITY OF WISCONSIN MADISON   (United States)

^q DUKE UNIVERSITY   (United States)

^r Department of Obstetrics Gynecology   (United States)

^s CASE WESTERN RESERVE UNIVERSITY   (United States)

^t UNIVERSITY OF OKLAHOMA   (United States)

^u UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^v TULANE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOLOGICAL PARAMETERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELOMA; PATIENT MONITORING; PRIORITY JOURNAL; SOLID TUMOR; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT OUTCOME;

EID: 77149173502     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0904084     Document Type: Article

References (27)

1. Tinmouth AT, Freedman J. Prophylactic platelet transfusions: which dose is the best dose? A review of the literature. Transfus Med Rev 2003;17:181-93.
2. Heddle NM. Controversy concerning platelet dose. ISBT Sci Ser 2007;2:220-5.
3. Stanworth SJ, Hyde C, Brunskill S, Murphy MF. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now? Br J Haematol 2005;131:588-95.
4. Norol F, Bieling P, Roudot-Thoraval F, et al. Platelet transfusion: a dose-response study. Blood 1998;92:1448-53.
5. Tinmouth A, Tannock IF, Crump M, et al. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design. Transfusion 2004;44:1711-9.
6. Heddle NM, Cook RJ, Tinmouth A, et al. A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood 2009;113:1564-73.
7. Slichter SJ. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients. J Clin Apher 2006;21:78-84.
8. SAS/STAT software, version 9.2. Cary, NC: SAS Institute, 2000-2008.
9. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer 1981;47:207-14.
10. Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 1997;337:1870-5.
11. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Arch Intern Med 1916;17:863-71.
12. Zelen M. The randomization and stratification of patients to clinical trials. J Chronic Dis 1974;27:365-75.
13. Cox DR, Oakes D. Analysis of survival data. London: Chapman & Hall, 1984.
14. Hardin JW, Hilbe JM. Generalized estimating equations. Boca Raton, FL: Chapman & Hall/CRC, 2003.
15. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
16. Whitaker BI, Green J, King MR, et al. The 2007 National Blood Collection and Utilization Survey report. (Accessed January 25, 2010, at http://www.hhs.gov/ophs/bloodsafety/2007nbcus-survey.pdf.)
17. Nevo S, Swan V, Enger C, et al. Acute bleeding after bone marrow transplantation (BMT) - incidence and effect on survival: a quantitative analysis in 1,402 patients. Blood 1998;91:1469-77.
18. Slichter SJ. Relationship between platelet count and bleeding risk in thrombocytopenic patients. Transfus Med Rev 2004;18:153-67.
19. Heddle NM, Cook RJ, Sigouin C, Slichter SJ, Murphy M, Rebulla P. A descriptive analysis of international transfusion practice and bleeding outcomes in patients with acute leukemia. Transfusion 2006;46:903-11.
20. Heddle NM, Cook RJ, Webert KE, Sigouin C, Rebulla P. Methodologic issues in the use of bleeding as an outcome in transfusion medicine studies. Transfusion 2003;43:742-52.
21. Wandt H, Frank M, Schaefer-Eckart K, Wilhelm M. Routine prophylactic platelet transfusions are not necessary in patients with acute myeloid leukemia - a therapeutic transfusion strategy is safe and cost effective. Blood 2005;106:129a. abstract.
22. McCullough J, Vesole DH, Benjamin RJ, et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial. Blood 2004;104:1534-41.
23. Hersh JK, Hom EG, Brecher ME. Mathematical modeling of platelet survival with implications for optimal transfusion practice in the chronically platelet transfusion-dependent patient. Transfusion 1998;38:637-44.
24. Brecher ME, Hom EG, Hersh JK. Optimal platelet dosing. Transfusion 1999;39:431-4.
25. Klumpp TR, Herman JH, Gaughan JP, et al. Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial. Transfusion 1999;39:674-81.
26. Sensebé L, Giraudeau B, Bardiaux L, et al. The efficiency of transfusing high doses of platelets in hematologic patients with thrombocytopenia: results of a prospective, randomized, open, blinded end point (PROBE) study. Blood 2005;105:862-4.
27. Goodnough LT, Kuter DJ, McCullough J, et al. Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood 2001;98:1346-51.